Holen Sie sich die Stockscreener-App
3.01
2.73%
0.08
Schlusskurs vom Vortag:
$2.93
Offen:
$3
24-Stunden-Volumen:
10,907
Relative Volume:
0.21
Marktkapitalisierung:
$88.72M
Einnahmen:
$4.01M
Nettoeinkommen (Verlust:
$-38.53M
KGV:
-2.3889
EPS:
-1.26
Netto-Cashflow:
$-32.27M
1W Leistung:
+3.44%
1M Leistung:
-4.14%
6M Leistung:
-59.05%
1J Leistung:
-62.47%
1-Tages-Spanne:
$2.95
$3.00
1-Wochen-Bereich:
$2.78
$3.12
52-Wochen-Spanne:
$2.65
$9.45
Xbiotech Inc Stock (XBIT) Company Profile
Firmenname
Xbiotech Inc
Sektor
Branche
Telefon
512-386-2900
Adresse
5217 WINNEBAGO LANE, AUSTIN, TX
Vergleichen Sie XBIT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XBIT
Xbiotech Inc
|
2.98 | 88.72M | 4.01M | -38.53M | -32.27M | -1.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
501.65 | 126.96B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
610.21 | 65.06B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
651.03 | 37.54B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
260.10 | 32.56B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
256.53 | 26.40B | 3.81B | -644.79M | -669.77M | -6.24 |
Xbiotech Inc Stock (XBIT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-06-14 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-04-21 | Herabstufung | Noble Financial | Buy → Hold |
| 2016-06-28 | Bestätigt | Noble Financial | Buy |
Xbiotech Inc Aktie (XBIT) Neueste Nachrichten
XBiotech (NASDAQ:XBIT) Share Price Crosses Below 50-Day Moving AverageTime to Sell? - MarketBeat
Press Release Distribution & PR Platform - ACCESS Newswire
XBiotech (NASDAQ:XBIT) Stock Passes Below Fifty Day Moving AverageWhat's Next? - MarketBeat
Top Premarket Gainers - marketscreener.com
XBiotech (NASDAQ:XBIT) Shares Pass Above Fifty Day Moving AverageHere's Why - MarketBeat
XBiotech Inc. (NASDAQ:XBIT) Shares Sold by American Century Companies Inc. - Defense World
XBiotech stock plunges to 52-week low at $2.91 amid market challenges - Investing.com Canada
XBiotech Inc. (NASDAQ:XBIT) Short Interest Down 23.1% in March - MarketBeat
XBiotech Announces Board Member Retirement - TipRanks
XBiotech (NASDAQ:XBIT) Shares Pass Above 50-Day Moving AverageWhat's Next? - MarketBeat
Bank of New York Mellon Corp Has $360,000 Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World
INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of XBiotech Inc. -- XBIT - ACCESS Newswire
XBiotech (NASDAQ:XBIT) Issues Quarterly Earnings Results - MarketBeat
XBiotech Inc. (XBIT) reports earnings - qz.com
Stocks Recover Some of This Week’s Losses as US Shutdown Seems Averted - TradingView
Stocks Rally as US Government Shutdown Risks Recede - TradingView
Tariff Worries Pressure Stocks - TradingView
XBiotech Inc.'s (NASDAQ:XBIT) 18% gain last week benefited both retail investors who own 49% as well as insiders - Simply Wall St
XBIT ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of XBiotech Inc. Shareholders Who Lost Money - ACCESS Newswire
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against XBiotech, Inc. (XBIT) and Lead Plaintiff Deadline: February 1, 2016 - ACCESS Newswire
Investor Network: XBiotech, Inc. to Host Earnings Call - ACCESS Newswire
XBiotech Inc. (NASDAQ:XBIT) Sees Large Growth in Short Interest - MarketBeat
Head to Head Contrast: Aurinia Pharmaceuticals (NASDAQ:AUPH) and XBiotech (NASDAQ:XBIT) - Armenian Reporter
XBiotech stock plunges to 52-week low, touches $3.03 - Investing.com India
XBiotech stock plunges to 52-week low, touches $3.03 By Investing.com - Investing.com Canada
Head-To-Head Analysis: Aurinia Pharmaceuticals (NASDAQ:AUPH) vs. XBiotech (NASDAQ:XBIT) - Defense World
Investing in XBiotech Inc (XBIT) might be a great opportunity, but the stock is a bit overvalued - US Post News
XBiotech Inc. (NASDAQ:XBIT) Short Interest Update - Defense World
XBIT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into XBiotech Inc. and Encourages Investors to Contact the Firm - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc.XBIT - PR Newswire
XBiotech stock hits 52-week low at $3.5 amid market challenges - MSN
Bronstein, Gewirtz & Grossman, LLC Is Investigating XBiotech Inc. (XBIT) And Encourages Shareholders to Connect - Markets Insider
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against XBiotech Inc. (XBIT) And Encourages Shareholders to Reach Out - Markets Insider
XBiotech Inc. (XBIT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider
Barclays PLC Boosts Stock Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World
Bronstein, Gewirtz & Grossman, LLC Encourages XBiotech Inc. (XBIT) Stockholders to Inquire about Securities Investigation - Markets Insider
Finanzdaten der Xbiotech Inc-Aktie (XBIT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.01%
2.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):